Request for Covid-19 Impact Assessment of this Report
Market Dynamics:
Innovation in products targeting specific age groups, sizes and medical conditions are gaining popularity in the industry. A trend of premiumisation and growing popularity of natural and organic products has also affected the industry. Customers are also interested in the origins of the products, to ensure authenticity. Many diseases such as coccidiosis and brucellosis explicitly affect some species of the companion animals and cause severe anomalies in the growth and reproduction of the animal. Growing awareness regarding such diseases and their impact on human health has also fuelled the growth of the market. The increasing costs of ingredients, shortfalls in local supplies and rising oil prices are expected to increase the cost of nutraceuticals and various animal healthcare products, constraining consumers from using commercial products. The Recent ban on some of the antibiotics has also hindered the growth of the market, to some extent.
Market Segmentation:
Based on type of products, the companion animal health market is segmented into Vaccines, Anti-infectives, Parasiticides, Medicinal feed additives, and other pharmaceuticals. On the basis of diagnostics, it is divided into Enzyme Linked Immuno sorbent assay (ELISA), Rapid Immuno Migration (RIM). The contemporary market of companion animal health is also divided based on genetics.
Geographical Analysis:
Europe holds the largest share of the animal healthcare market, followed by North America. The developing regions like Asia-pacific and Africa are expected to form a new revenue pocket in the market. Countries such as India, China, and Brazil will be the major contributors in the market. Increasing disposable incomes, growing urbanization and development of pet culture in these countries are the primary reasons behind the growth of the market in these countries.
Key Players
Some of the key players in the market include Pfizer (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada, Inc. (Canada), and Ceva (France).
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
Driven by improving living standards of people and a fast-growing macro-economy, China has remained the largest beer-consuming country worldwide for the 12th consecutive year since 2003, and the largest beer-producing nation globally in the past years. This report focuses on systematic evaluation and analysis of Internal Risks (arising within the industry development itself) and External Risks (ar...
Summary Based on products type, the report describes major products type share of regional market. Products mentioned as follows: By Type Microparticulated Protein Modified Whey Protein Concentrate Others Based on region, the report describes major regions market by vendor, products and application. Regions mentioned as follows: North America Europe Asia RoW Based on application, the repor...
Summary The global Oat Protein market is estimated to reach 1.4 K MT in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regio...